NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo announced a quarterly dividend on Thursday, February 14th. Stockholders of record on Friday, March 1st will be given a dividend of $0.19 per share on Tuesday, March 19th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.61%. The ex-dividend date is Thursday, February 28th. View Perrigo's Dividend History.

Perrigo Company PLC (NYSE:PRGO) posted its earnings results on Wednesday, February, 27th. The company reported $0.97 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.00 by $0.03. The business had revenue of $1.20 billion for the quarter, compared to analysts' expectations of $1.18 billion. Perrigo had a net margin of 2.77% and a return on equity of 10.74%. The company's revenue for the quarter was down 6.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.28 earnings per share. View Perrigo's Earnings History.

Perrigo is scheduled to release their next quarterly earnings announcement on Tuesday, May 14th 2019. View Earnings Estimates for Perrigo.

14 analysts have issued twelve-month target prices for Perrigo's stock. Their predictions range from $47.00 to $110.00. On average, they expect Perrigo's share price to reach $75.5333 in the next year. This suggests a possible upside of 59.9% from the stock's current price. View Analyst Price Targets for Perrigo.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 11 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

Media coverage about PRGO stock has trended neutral on Monday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Perrigo earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an effect on the stock's share price in the next several days.

Some companies that are related to Perrigo include Teva Pharmaceutical Industries (TEVA), UCB (UCBJF), BioMarin Pharmaceutical (BMRN), Ono Pharmaceutical (OPHLF), Mylan (MYL), Merck KGaA (MKGAF), GRIFOLS S A/S (GRFS), Ionis Pharmaceuticals (IONS), Genmab A/S (GNMSF), Alnylam Pharmaceuticals (ALNY), Sarepta Therapeutics (SRPT), Bausch Health Companies (BHC), Jazz Pharmaceuticals (JAZZ), Beigene (BGNE) and SAGE Therapeutics (SAGE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Celgene (CELG), Twitter (TWTR), Mylan (MYL), Allergan (AGN), General Electric (GE), Amgen (AMGN), Intel (INTC) and Starbucks (SBUX).

Perrigo's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.23%), FMR LLC (5.96%), Clal Insurance Enterprises Holdings Ltd (1.74%), Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.29%), Geode Capital Management LLC (1.24%) and Geode Capital Management LLC (1.24%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Murray S Kessler, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Victory Capital Management Inc., Iridian Asset Management LLC CT, Parnassus Investments CA, Manning & Napier Group LLC, Mackenzie Financial Corp, Menora Mivtachim Holdings LTD. and Canada Pension Plan Investment Board. View Insider Buying and Selling for Perrigo.

PRGO stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Norges Bank, Dimensional Fund Advisors LP, Clal Insurance Enterprises Holdings Ltd, First Trust Advisors LP, Geode Capital Management LLC, Geode Capital Management LLC and TD Asset Management Inc.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Murray S Kessler, Svend Andersen, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $47.25.

Perrigo has a market capitalization of $6.42 billion and generates $4.73 billion in revenue each year. The company earns $131 million in net income (profit) each year or $4.55 on an earnings per share basis. Perrigo employs 10,600 workers across the globe.

The official website for Perrigo is http://www.perrigo.com.

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]